A new way to medicate: Light
UNC researchers have developed a medicine delivery technique using light that can target specific parts of the body.
David Lawrence, a Fred Eshelman distinguished professor in the Eshelman School of Pharmacy, professor in the College of Arts and Science and School of Medicine and member of the UNC Lineberger Comprehensive Cancer Center, led a team of researchers in developing the technique. Their work is published in the journal Angewandte Chemie in late November of last year.
The system works by initially binding medicine to red blood cells using vitamin B12, then releasing them into the body using light. The bond between the B12 and medicine is made just weak enough so long-wavelength light — which is low in energy and less damaging than short-wavelength light — can separate the blood cells from the medicine when a small fluorescent molecule is introduced to capture the light.
From there, the medicine can be released into the body at specific areas and times. Since the cells can circulate in the body for up to four months, the technique could decrease the amount of medicine needed for individuals.
To research how this technique can be performed on humans, Lawrence partnered with the University to create Iris BioMed, a drug delivery company.
Lawrence said the benefits of the technique may include making treatment accessible for people at home, decreasing the need for surgery and allowing individuals who need multiple medicines — such as cancer patients — to focus their medicine in an area, decreasing medicine-related symptoms.